Cautious medtech sees surgery rebound
Much delayed and needed elective surgeries are getting back on track as the latest wave of COVID-19 infections eases.
Investing. Plain and simple.
Much delayed and needed elective surgeries are getting back on track as the latest wave of COVID-19 infections eases.
The healthcare sector offers safety and stability because the companies tend to perform well in all economic conditions.
Delayed surgeries are being rescheduled and more people are visiting their doctors.
Opinions differ on whether recovery will bring on a spending spree.
As global healthcare systems look for ways to cope with the COVID-19 pandemic, one place they are turning to is robots.
As robot-assisted surgeries grow, Stryker Corp. and Medtronic Inc.are gaining from investments in theses tools.
Medtronic was recently given approval for the world’s smallest pacemaker, about 20 times smaller than a conventional device .
The healthcare sector is benefiting from trendsĀ that are creating products and services we all need in good times and bad.
Healthcare is one sector that tends to perform better in a recession than others.
Medtronic’s latest earnings beat expectations for the 14th quarter in a row.
You must be logged in to post a comment.